Related Experiment Videos
[Apolipoprotein E polymorphism as a predictor of progression of multiple sclerosis]
A L Guerrero1, V Bueno, M T Hernández
1Unidad de Neurología, Hospital Río Carrión, Palencia, Spain. aguerrerop@medynet.com
Neurologia (Barcelona, Spain)
|April 5, 2003
Summary
The apolipoprotein E e4 allele does not predict multiple sclerosis progression. This study found no significant correlation between the e4 allele and disease markers in patients with multiple sclerosis.
Area of Science:
- Neuroimmunology
- Genetics
- Neurology
Context:
- Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- The apolipoprotein E (APOE) gene, particularly the e4 allele, has been investigated as a potential predictor of disease progression in MS.
Purpose:
- To investigate the association between the apolipoprotein E e4 allele and markers of disability progression in patients with multiple sclerosis.
Summary:
- This study analyzed 42 patients with relapsing-remitting or secondary progressive multiple sclerosis.
- Correlations between the APOE e4 allele and various progression markers (age of onset, disease duration, relapses, EDSS, progression index, relapse rate) were assessed.
- No statistically significant correlation was found between the presence of the APOE e4 allele and any of the evaluated progression parameters.
Impact:
- The findings suggest that APOE e4 may not be a reliable predictor of multiple sclerosis progression in the studied cohort.
- Further research with larger sample sizes is needed to definitively confirm or refute this association.